Relmada Therapeutics, Inc. is a clinical stage, publicly traded biotechnology company, developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of central nervous system (CNS) diseases.
Learn More About Relmada Therapeutics2nd Annual Disruptive Growth & Healthcare Conference